The company believes that OTL-200 offers tremendous potential to transform the lives of many young patients with MLD... Nov 21
This collaboration will help to accelerate the work aimed to solve genetic diseases with unique editing challenges... Nov 21
RHB-204 is being evaluated as a first-line, stand-alone, oral treatment for pulmonary nontuberculous mycobacteria (NTM) disease ... Nov 21
A study of measles-mumps-rubella titers and SARS-CoV-2 infection severity was published in mBio, the open-access journal of the American Society ... Nov 21
VFMCRP and Fresenius Kabi will deliver a treatment that will enable patients to remain on RAASi therapy by managing their chronic hyperkalemia... Nov 21
AskBio and Selecta expect to initiate a Phase 1 clinical trial of MMA-101 and ImmTOR for patients with MMA in the first half of ... Nov 21
-Advertisements-